股溜產業平台

浩宇生醫

6872上櫃
17.05−0.60−3.40%收盤・資料日 2026-11-06

營收與獲利單位：億元；資料到 2026 Q3

2026 Q30.02 億元0.00 億元−0.38 億元−0.37 億元

營收與獲利（億元；單季）

22Q122Q323Q123Q324Q124Q325Q125Q326Q126Q3

損益表單位：億元（每股盈餘：元）；單季，最新在左

科目2026 Q32026 Q22026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q4
營業收入淨額0.020.030.180.020.040.040.010.100.130.050.000.02—0.20—0.07—0.13——
營業成本0.030.030.080.030.030.040.030.040.070.050.020.04—0.07—0.01—0.02——
營業毛利0.000.000.10−0.010.01−0.01−0.020.060.060.01−0.02−0.01—0.13—0.06—0.11—−0.01
營業費用0.380.450.450.470.400.340.370.280.370.320.240.49—0.39—0.50—0.43—0.51
推銷費用0.010.020.030.060.010.020.020.020.040.020.020.04—0.03—0.04—0.03—0.02
管理費用0.070.080.090.080.060.070.090.060.070.070.050.12—0.10—0.10—0.09—0.13
研究發展費用0.300.350.330.340.320.250.260.200.260.230.160.33—0.26—0.34—0.30—0.35
預期信用減損損失（利益）———————————0.00—0.00—0.03—0.01——
營業利益−0.38−0.45−0.35−0.48−0.39−0.34−0.39−0.22−0.31−0.31−0.26−0.50—−0.26—−0.44—−0.32—−0.51
營業外收入及支出0.010.010.070.040.03−0.060.090.06−0.020.050.04−0.01—0.08—0.07—0.06—−0.01
稅前淨利−0.37−0.44−0.28−0.44−0.36−0.40−0.30−0.16−0.33−0.27−0.22−0.51—−0.18—−0.37—−0.26—−0.52
所得稅費用0.070.080.090.080.060.070.090.060.070.070.050.12—0.10—0.10—0.09—0.13
繼續營業單位損益−0.37−0.44−0.28−0.44−0.36−0.40−0.30−0.16−0.33−0.27−0.22−0.51—−0.18—−0.37—−0.26—−0.52
本期淨利（稅後）−0.37−0.44−0.28−0.44−0.36−0.40−0.30−0.16−0.33−0.27−0.22−0.51—−0.18—−0.37—−0.26—−0.52
歸屬母公司業主−0.36−0.44−0.29−0.43−0.35−0.39−0.31−0.16−0.32−0.26−0.22−0.49—−0.17—−0.36—−0.27—−0.52
歸屬非控制權益−0.01−0.010.01−0.01−0.01−0.010.01−0.01−0.01−0.010.00−0.03—−0.01—−0.01—0.01—0.00
本期綜合損益總額−0.37−0.44−0.27−0.43−0.35−0.42−0.30−0.18−0.32−0.26−0.22−0.51—−0.19—−0.37—−0.26—−0.53
綜合損益歸屬母公司業主−0.35−0.44−0.28−0.42−0.34−0.41−0.31−0.17−0.31−0.25−0.22−0.48—−0.17—−0.36—−0.27—−0.53
綜合損益歸屬非控制權益−0.01−0.010.01−0.01−0.01−0.010.01−0.01−0.010.00−0.01−0.02—−0.01—−0.01—0.01—0.00
每股盈餘（元）−0.50−0.62−0.41−0.60−0.50−0.56−0.48−0.25−0.51−0.42−0.38−0.87—−0.30—−0.65—−0.48—−1.05

股溜產業平台 產業資訊整理，不構成投資建議；數字以證交所、櫃買中心、集保公告為準。 資料日 2026-11-06